| Line Item | 2023-12-31 | Y/Y |
|---|---|---|
| R&D Expense | $72.0M | +17.9% |
| SG&A Expense | $35.5M | +31.4% |
| Operating Income | -$107.5M | -22.8% |
| Interest Expense | $5.8M | +44.7% |
| Pre-tax Income | -$101.1M | -7.7% |
| Income Tax | $78K | +178.6% |
| Net Income | -$101.2M | -7.8% |
| EPS (Basic) | -$0.57 | +62.5% |
| EPS (Diluted) | -$0.57 |
| Line Item | 2023-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $99.2M | -18.5% |
| Current Assets | $122.1M | -5.1% |
| Total Assets | $147.3M | -5.4% |
| Current Liabilities | $22.9M | +2.4% |
| Long-term Debt | $55.0M | +69.2% |
| Total Liabilities | $96.2M | +17.9% |
| Stockholders' Equity | $51.1M | -31.0% |
| Line Item | 2023-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$96.5M | -25.2% |
| Investing Cash Flow | -$14.9M | — |
| Financing Cash Flow | $88.5M | -24.5% |
| +62.5% |